Lanzatech co-founder: we are missing out on the synthetic biology revolution

Lanzatech co-founder: we are missing out on the synthetic biology revolution
Dr Sean Simpson. (Image: Getty)
Peter Griffin
The third New Zealand-founded company in as many years is set to list on the Nasdaq.LanzaTech’s merger with “blank cheque” Nasdaq-listed company AMCI Acquisition Corp II sees it follow in the footsteps of Rocket Lab and footwear maker All Birds in taking the special purpose acquisition company (SPAC) route to become a publicly traded company.The deal, which values the merged company at around US$1.8 billion (NZ$2.8b), was cleared by shareholders on Tuesday. It confirms the Illinois-based LanzaTech’s status as our mo...

More Opinion

Carmageddon: to buy shares, or not to
Opinion

Simon Robertson: Carmageddon: to buy shares, or not to

A basic early investing rule: never own airline or car company shares.

Red tape? More scissors, less string please
Opinion

Deb Te Kawa: Red tape? More scissors, less string please

We need a complete rethink of how we approach regulation in Aotearoa New Zealand.

Deb Te Kawa 13 Dec 2024
Is advertising ready for the giant babushka?
Opinion

Kelly Bennett: Is advertising ready for the giant babushka?

Advertising was built on mergers but has not seen anything like IPG and Omnicom joining.

Kelly Bennett 13 Dec 2024
Microsoft’s shiny new NZ datacentre
Opinion

Peter Griffin: Microsoft’s shiny new NZ datacentre

NZ is a sort of experiment demonstrating the role of high-capacity infrastructure.

Peter Griffin 12 Dec 2024